| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8751001 | Revue de Pneumologie Clinique | 2018 | 4 Pages |
Abstract
When the tolerance of the pentoxifylline is good and there is not a bleeding risk, the benefit-risk in the long term might be interesting in some patients with sarcoidosis corticodependent.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Infectious Diseases
Authors
B.D. Diallo, B. Diot, T. Flament, L. Plantier, P. Diot, O.Y. Sow, S. Marchand-Adam,